Myriad Genetics director Mark Steven Davis reports sale of $34,251.50 in common shares
MYGN•Director Mark Steven Davis sold 6,100 Myriad Genetics common shares for $5.615 each on Nov. 18, 2026, for $34,251.50. A Form 4 filing listed his remaining direct holdings at 100,565 shares.




